sb 203580 has been researched along with tan 67 in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (tan 67) | Trials (tan 67) | Recent Studies (post-2010) (tan 67) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 62 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fryer, RM; Gross, GJ; Hsu, AK | 1 |
Fryer, RM; Gross, GJ; Hsu, AK; Patel, HH | 1 |
2 other study(ies) available for sb 203580 and tan 67
Article | Year |
---|---|
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection.
Topics: Analgesics; Animals; Blood Pressure; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heart Rate; Imidazoles; Ischemic Preconditioning, Myocardial; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyridines; Quinolines; Rats; Rats, Wistar; Receptors, Opioid | 2001 |
Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium.
Topics: Animals; Coronary Vessels; Cytoprotection; Enzyme Inhibitors; Hemodynamics; Imidazoles; Ischemic Preconditioning, Myocardial; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta; Reperfusion Injury | 2001 |